4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-24-032432
Director sold 32,323 shares at an average $69.84 ($2,257,449)
- Director acquired 32,323 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| JEFFS ROGER Director | 2024-03-14 | Option exercise 10b5-1 | +13,000 | $22.03 | $286,390 | 133,756 | D |
| JEFFS ROGER Director | 2024-03-14 | Sale 10b5-1 | −13,000 | $69.70 | $906,126 | 120,756 | D |
| JEFFS ROGER Director | 2024-03-14 | Option exercise 10b5-1 | +16,976 | $25.53 | $433,397 | 137,732 | D |
| JEFFS ROGER Director | 2024-03-14 | Sale 10b5-1 | −16,976 | $69.70 | $1,183,261 | 120,756 | D |
| JEFFS ROGER Director | 2024-03-15 | Option exercise 10b5-1 | +2,347 | $29.91 | $70,199 | 123,103 | D |
| JEFFS ROGER Director | 2024-03-15 | Sale 10b5-1 | −2,347 | $71.61 | $168,062 | 120,756 | D |
| Derivatives | |||||||
| JEFFS ROGER Director | 2024-03-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,000 | 0 | D | ||
| JEFFS ROGER Director | 2024-03-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,976 | 0 | D | ||
| JEFFS ROGER Director | 2024-03-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,347 | 0 | D | ||
| Open-market sales · 32,323 sh · avg $69.84 · $2,257,449 | |||||||
Loading xslF345X05/ownership.xml…